Eu Yan Sang delisting not yet in the bag
THE two funds holding substantial stakes in Eu Yan Sang amid a consortium's takeover offer for the traditional Chinese medicine retailer have already prevented the offeror from carrying out a 'squeeze-out' compulsory acquisition of the remaining shares it does not already own.
But that may not be the consortium's only problem as the closing of the offer on Aug 15 approaches. There is also an interesting possibility that the two funds could by some clever tactics block Eu Yan Sang from delisting altogether, if that is in fact their aim.
If it is and they manage to work with each other to pull that off, they would have together accomplished what other funds have attempted and failed to do in recent cases, such as the privatisations of property developer Singapore Land in 2014 and of engineering firm UE E&C in 2015.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Columns
‘Competition for talent’ a poor excuse to keep key executives’ pay under wraps
OCBC should put its properties into a Reit and distribute the trust’s units to shareholders
Why a stronger US dollar is dangerous
An overstimulated US economy is asking for trouble
Too many property agents? Cap commissions on home sales
Time to study broadening of private market access